Lou Basenese - 11 Jun 2025 Form 4 Insider Report for ENDRA Life Sciences Inc. (NDRA)

Role
Director
Signature
/s/ Lou Basenese by Mark Busch, attorney-in-fact
Issuer symbol
NDRA
Transactions as of
11 Jun 2025
Net transactions value
$0
Form type
4
Filing time
01 Jul 2025, 06:26:33 UTC
Previous filing
27 May 2025
Next filing
03 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Basenese Lou Director C/O ENDRA LIFE SCIENCES INC., 3600 GREEN COURT, SUITE 350, ANN ARBOR /s/ Lou Basenese by Mark Busch, attorney-in-fact 01 Jul 2025 0001809482

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NDRA Common Stock Award $0 +5,384 +538400% $0.000000 5,385 11 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 11, 2026.